Dr MBA - Voyager Therapeutics Chief Officer

VYGR Stock  USD 5.75  0.06  1.05%   

Executive

Dr MBA is Chief Officer of Voyager Therapeutics
Age 47
Address 75 Hayden Avenue, Lexington, MA, United States, 02421
Phone857 259 5340
Webhttps://www.voyagertherapeutics.com

Voyager Therapeutics Management Efficiency

The company has return on total asset (ROA) of 0.0157 % which means that it generated a profit of $0.0157 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.1022 %, meaning that it created $0.1022 on every $100 dollars invested by stockholders. Voyager Therapeutics' management efficiency ratios could be used to measure how well Voyager Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities.
Voyager Therapeutics currently holds 20.29 M in liabilities with Debt to Equity (D/E) ratio of 0.4, which is about average as compared to similar companies. Voyager Therapeutics has a current ratio of 1.52, which is within standard range for the sector. Note, when we think about Voyager Therapeutics' use of debt, we should always consider it together with its cash and equity.

Similar Executives

Showing other executives

EXECUTIVE Age

Cindy TahlFate Therapeutics
51
Timothy MBACaribou Biosciences
55
Barbara HickingbottomFate Therapeutics
N/A
Amy CFACaribou Biosciences
N/A
Terry MDSana Biotechnology
57
Christian MBASana Biotechnology
41
Andrew HenryFate Therapeutics
60
Jennifer JarrettArcus Biosciences
50
Elhan CFAKaryopharm Therapeutics
N/A
Snehal PatelSana Biotechnology
N/A
Edward RebarSana Biotechnology
56
Richard MulliganSana Biotechnology
69
Yvonne GehringArcus Biosciences
N/A
Matthew BeckHookipa Pharma
N/A
MBA MDX4 Pharmaceuticals
62
Bahram ValamehrFate Therapeutics
47
Ryan FischesserCaribou Biosciences
N/A
Brian AustadKaryopharm Therapeutics
N/A
Cindy JDFate Therapeutics
51
Mark MBAX4 Pharmaceuticals
60
Jerome BressiFate Therapeutics
N/A
Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. Voyager Therapeutics, Inc. was incorporated in 2013 and is headquartered in Cambridge, Massachusetts. Voyager Therapeut operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 101 people. Voyager Therapeutics (VYGR) is traded on NASDAQ Exchange in USA. It is located in 75 Hayden Avenue, Lexington, MA, United States, 02421 and employs 162 people. Voyager Therapeutics is listed under Biotechnology category by Fama And French industry classification.

Management Performance

Voyager Therapeutics Leadership Team

Elected by the shareholders, the Voyager Therapeutics' board of directors comprises two types of representatives: Voyager Therapeutics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Voyager. The board's role is to monitor Voyager Therapeutics' management team and ensure that shareholders' interests are well served. Voyager Therapeutics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Voyager Therapeutics' outside directors are responsible for providing unbiased perspectives on the board's policies.
Sandrock MD, CEO Pres
Dr MBA, Chief Officer
Trista Morrison, Chief CEO
JD Esq, Chief Officer
Andre Turenne, President CEO
Todd Carter, Chief Officer
Robert Hesslein, Senior Vice President General Counsel
Robin Swartz, Chief Officer
Krystof MD, Founder
Guangping Gao, Founder Board
Peter CPA, Chief Officer
Phillip Zamore, Founder Board
Michelle Smith, Chief Officer

Voyager Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Voyager Therapeutics a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Pair Trading with Voyager Therapeutics

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Voyager Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Voyager Therapeutics will appreciate offsetting losses from the drop in the long position's value.

Moving against Voyager Stock

  0.42VCEL Vericel Corp OrdPairCorr
The ability to find closely correlated positions to Voyager Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Voyager Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Voyager Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Voyager Therapeutics to buy it.
The correlation of Voyager Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Voyager Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Voyager Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Voyager Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Additional Tools for Voyager Stock Analysis

When running Voyager Therapeutics' price analysis, check to measure Voyager Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Voyager Therapeutics is operating at the current time. Most of Voyager Therapeutics' value examination focuses on studying past and present price action to predict the probability of Voyager Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Voyager Therapeutics' price. Additionally, you may evaluate how the addition of Voyager Therapeutics to your portfolios can decrease your overall portfolio volatility.